Equities researchers at StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM - Get Free Report) in a research note issued to investors on Friday. The firm set a "sell" rating on the stock.
Separately, Craig Hallum raised shares of Streamline Health Solutions to a "strong-buy" rating in a research report on Thursday, September 5th.
Read Our Latest Research Report on STRM
Streamline Health Solutions Stock Down 3.1 %
Shares of STRM traded down $0.06 during trading hours on Friday, reaching $1.94. The stock had a trading volume of 22,334 shares, compared to its average volume of 15,712. Streamline Health Solutions has a 52 week low of $1.92 and a 52 week high of $9.75. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.61 and a quick ratio of 0.61. The firm has a 50-day moving average of $4.66 and a 200 day moving average of $5.76.
Streamline Health Solutions (NASDAQ:STRM - Get Free Report) last released its earnings results on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.15). Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%. The firm had revenue of $4.48 million during the quarter.
Streamline Health Solutions Company Profile
(
Get Free Report)
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Further Reading
Before you consider Streamline Health Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Streamline Health Solutions wasn't on the list.
While Streamline Health Solutions currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
